Barbara Leyman

Company: Sutro Biopharma

Job title: Chief Business Development Officer

Bio:

Barbara joined Sutro in 2024 and she brought 20 years of deal making experience in life sciences to the company. Prior to Sutro, she worked at GenEdit, where she oversaw business development, alliance management and corporate strategy. At GenEdit, she successfully led the business development efforts towards the execution of the multiyear collaboration and license agreement with Genentech for a total deal value of $644M. Prior to joining GenEdit, she held positions of increasing responsibility in business development and corporate strategy at Lyell Immunopharma and Calico Life Sciences. In those positions, she led licensing, R&D collaborations and co-development transactions through due diligence, negotiation and execution.

Seminars:

ADC Deal-Making: Will Success Lead to More Success? 2:10 pm

Discussing opportunity for and examples of creative deal structures across ADCs  For payloads: Do you need the full ADC payload for a deal? For linkers: What drives deals with different types of linkers?  For target discovery: What are the differences in deal structure versus linkers and payloads? Sharing guidance to progress from a research collaboration…Read more

day: Conference Day Two